New report outlines cost of inaction on AMR ahead of UN high-level meeting
In September 2024, the UN General Assembly will host its second high-level meeting on antimicrobial resistance (AMR). The Global Leaders Group (GLG) on Antimicrobial Resistance has been tasked with supporting preparations for the meeting. On April 4, 2024, the GLG released a new report outlin-ing recommendations to inform discussions at the high-level meeting alongside several proposed targets. An economic study commissioned for the report projected that by 2035, without substantial action on AMR, global life expectancy would drop by 1·8 years, the cost to health care of treating antibiotic resistant infections would reach US$412 billion per year, and productivity losses resulting from AMR would reach $443 billion per year.